The FDA is requiring labeling changes on opioid painkillers to reflect the risks of long-term use. “I’m always going to be ...

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's opioid addiction problem.

On Tuesday, opioid experts met with legislators for a virtual summit to discuss issues they would like to see considered in ...

The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse ...

The U.S. Food and Drug Administration has recommended regulating specific products with 7-hydroxymitragynine under the ...

Routinely offering and initiating medication-based treatment for those with opioid use disorder has the potential to save ...

Etonitazene, a superstrong lab-made substance, is contaminating street heroin and contributing to a new rise in Scottish drug deaths.

The new rule comes after a public advisory committee meeting in May that reviewed data showing risks for patients who use opioids over long periods. Those risks include misuse, addiction and overdoses ...

OH is not regulated, and so products like chewable tablets or gummies can be legally sold at places like vape shops or gas ...

The latest data available on the Alberta government’s “substance use surveillance” dashboard shows there were 83 ...

Opioid use disorder refers to a problematic pattern of opioid use leading to clinically significant impairment or distress, as defined by the Diagnostic and Statistical Manual of Mental Disorders, ...

The FDA recommended classifying 7-OH as a Schedule I controlled substance due to its opioid-like effects and its use in ...